Amyotrophic Lateral Sclerosis: Accelerating Treatments and Improving Quality of Life- Meeting #2

Amyotrophic lateral sclerosis (ALS) is a rapidly progressive, invariably fatal neurological disease that attacks motor neurons and leads to their gradual degeneration and death, often within two years of onset. Currently, no treatments exist to stop or reverse the disease. This is the second meeting of a study committee mandated by Congress and sponsored by the National…

Unequal Treatment Revisited: Part 3

On September 6, 2023, the National Academies’ ad hoc Committee on Unequal Treatment Revisited will host the third public workshop in a virtual series examining federal efforts and initiatives aimed at reducing racial and ethnic inequities in health care access, utilization, and quality. Leaders from several government agencies will provide insights and answer questions during a panel…